16 May 2023
The PECTUS trial, OCT for identification of vulnerable plaques and its impact on clinical outcomes
Sponsored by Abbott
Summary
Niels Van Royen and Lorenz Räber discuss a very emerging topic: the vulnerable plaque, and more specifically the related PECTUS Trial. They address the question of why vulnerable plaques should be detected and what can be done with the results, before looking at the study design and results in detail, which provide evidence that the use of OCT can identify patients at increased risk.
Watch this video to learn more about OCT and its relevance for practice!
This interview was filmed at EuroPCR 2023: see more videos here!